Suppr超能文献

放射治疗与热疗联合治疗不可切除肝细胞癌

Combined treatment of radiotherapy and hyperthermia for unresectable hepatocellular carcinoma.

作者信息

Seong J, Lee H S, Han K H, Chon C Y, Suh C O, Kim G E

机构信息

Department of Radiation Oncology, Yonsei University College of Medicine, Seoul, Korea.

出版信息

Yonsei Med J. 1994 Sep;35(3):252-9. doi: 10.3349/ymj.1994.35.3.252.

Abstract

Eighty-four patients with unresectable primary hepatocellular carcinoma due either to locally advanced lesion or to association with liver cirrhosis were treated with combined radiotherapy and hyperthermia from April 1988 to January 1991. Purpose of this study was to assess thermometry, response rate, toxicity, and survival in those patients. External radiotherapy was given with a total of 30.6 Gy/3.5 wks. Hyperthermia was given twice a week with a total of 6 treatment sessions using an 8 MHz radiofrequency capacitive type heating machine. Each hyperthermia session was started within 30 min following radiotherapy and continued for 30-60 min. Thermal data were analysed with maximum, minimum, and average temperatures of the tumors. Thermal mapping was also done. In thermometry results, maximum, minimum, and average temperatures of the tumors were 41.9 +/- 1.3 degrees C, 39.9 +/- 1.0 degrees C, and 40.8 +/- 0.9 degrees C, respectively. The fraction over 40 degrees C was 73 +/- 32% with a wide variation from 15% to 100%. Among 67 assessable patients, 27 patients showed tumor regression of more than 50% of the original tumor volume (40.3% response rate). Symptomatic improvement was observed in 78.6% of the patients. Acute toxicities during the treatment were mostly acceptable local pain (51.2%) and local fat necrosis (13.1%). The actuarial 1-year, 2-year, and 3-year survival rates were 44.8%, 19.7%, and 15.6%, respectively. Median survival was 6 months. In view of acceptable toxicities and the current rate of survival, further evaluation of combined treatment of radiotherapy and hyperthermia for unresectable hepatocellular carcinoma is warranted.

摘要

1988年4月至1991年1月,84例因局部晚期病变或合并肝硬化而无法切除的原发性肝细胞癌患者接受了放射治疗和热疗联合治疗。本研究的目的是评估这些患者的体温测量、缓解率、毒性和生存率。外照射放疗总量为30.6 Gy/3.5周。使用8 MHz射频电容式加热机,每周进行2次热疗,共6次治疗。每次热疗在放疗后30分钟内开始,持续30 - 60分钟。分析肿瘤的最高、最低和平均温度的热数据。还进行了热图绘制。在体温测量结果中,肿瘤的最高、最低和平均温度分别为41.9±1.3℃、39.9±1.0℃和40.8±0.9℃。超过40℃的部分为73±32%,变化范围从15%到100%。在67例可评估的患者中,27例患者的肿瘤缩小超过原始肿瘤体积的50%(缓解率为40.3%)。78.6%的患者有症状改善。治疗期间的急性毒性大多为可接受的局部疼痛(51.2%)和局部脂肪坏死(13.1%)。1年、2年和3年的精算生存率分别为44.8%、19.7%和15.6%。中位生存期为6个月。鉴于毒性可接受以及当前的生存率,有必要对无法切除的肝细胞癌的放疗和热疗联合治疗进行进一步评估。

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验